Literature DB >> 11173602

Intracerebral Human Lymphoma - An Experimental Model.

János Schnur, Andrea Ladányi, László Kopper.   

Abstract

Primary central nervous system lymphomas are rather rare, however, their frequency seems to be increasing in both high risk and immunocompetent patients with very poor prognosis. Here we describe a model intracerebrally xenotransplating human non Hodgkin lymphoma cells of B cell origin (HT 58). This offers a unique possibility to study the theraputic response, especially on systemic treatment. Briefly, one million lymphoma cells grew as meningeal tumor mass, infiltrating the brain directly as well as via the perivascular space. The lymphoma cells preserved all the phenotypic characteristics of the source tumor.

Entities:  

Year:  1996        PMID: 11173602     DOI: 10.1007/bf02903522

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  16 in total

1.  Combined therapy for primary central nervous system lymphoma in immunocompetent patients.

Authors:  A J Ferreri; M Reni; A Bolognesi; C Verusio; E Villa
Journal:  Eur J Cancer       Date:  1995-11       Impact factor: 9.162

2.  Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.

Authors:  D C Miller; F H Hochberg; N L Harris; M L Gruber; D N Louis; H Cohen
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

3.  The therapeutic response of three human tumor lines maintained in immune-suppressed mice.

Authors:  L Kopper; G G Steel
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

4.  Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure.

Authors:  K Pál; L Kopper; K Lapis
Journal:  Invasion Metastasis       Date:  1983

5.  Primary non-Hodgkin lymphomas of the CNS. Classification, tissue reaction and proliferative activity.

Authors:  M Bergmann; K Kuchelmeister; G Edel; A Heinecke
Journal:  Zentralbl Pathol       Date:  1993-03

Review 6.  Primary central nervous system lymphomas--new pathological developments.

Authors:  K A Jellinger; W Paulus
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Human brain tumor xenografts in nude mice as a chemotherapy model.

Authors:  D P Houchens; A A Ovejera; S M Riblet; D E Slagel
Journal:  Eur J Cancer Clin Oncol       Date:  1983-06

Review 8.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

9.  Malignant lymphoma of the central nervous system in Japan: histologic and immunohistologic studies.

Authors:  K Aozasa; M Ohsawa; H Yamabe; N Shima; K Kirimoto; T Yamane; M Tsujimoto; Y Kobayashi; A Kurata; H Osada
Journal:  Int J Cancer       Date:  1990-04-15       Impact factor: 7.396

10.  Trends in primary cerebral lymphoma.

Authors:  J M Lutz; M P Coleman
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more
  1 in total

1.  Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Miaoxia He; Changjing Zuo; Jianjun Wang; Jianmin Liu; Binghua Jiao; Jianmin Zheng; Zailong Cai
Journal:  Neuro Oncol       Date:  2013-03-12       Impact factor: 12.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.